DAB2IP and prostate cancer: As a partial answer to this question, we and others found that treatment with conditioned medium from breast and prostate cancer cells induces DAB2IP downregulation in receiving non-transformed cells, stimulating proliferation, migration, and tube-forming ability of endothelial cells [47, 49, 53].